Jean-Francois Tanguay, M.D.
Jean-Francois Tanguay, M.D.
Montreal Heart Institute
Montreal,
QC
Canada
Biographical Sketch: Dr. Tanguay, MD, FRCPC, FCCS, FACC is Chief of the MHI Interventional Cardiology Division combining work in the CCU and the catheterization laboratory (1995-ongoing). Full professor at the Faculty of Medicine of the Université de Montréal and was President of the CAIC (2002-2005) and Director of the Interventional Cardiology Montreal Symposium (2004-2015). He was Co-Chair of the CCS Anti Platelet Guidelines Committee published in the Canadian Journal of Cardiology in 2011, 2013, and 2018.
His research focused on understanding the interactions between platelets, leukocytes and endothelial cells in ACS & PCI in order to improve vascular healing. Dr. Tanguay’s investigations brought promising discoveries related to 17beta-estradiol and the specific contribution of estrogen receptors in vascular healing. During his research fellowship, Dr Tanguay studied the early prototypes of bioresorbable DES platforms in pre-clinical models. At MHI, he performed the first coronary implantation of a drug-eluting bioresorbable scaffold (ABSORB) in North-America.
Papers: